Palatin Announces FDA Clearance of Ind Application for the Co-Administration of Bremelanotide With Tirzepatide (GLP-1) for the Treatment of Obesity
帕拉汀宣布美国食品药品管理局批准了布雷美拉诺肽与替塞帕肽(GLP-1)联合给药治疗肥胖的印度申请
Palatin Announces FDA Clearance of Ind Application for the Co-Administration of Bremelanotide With Tirzepatide (GLP-1) for the Treatment of Obesity
帕拉汀宣布美国食品药品管理局批准了布雷美拉诺肽与替塞帕肽(GLP-1)联合给药治疗肥胖的印度申请
使用浏览器的分享功能,分享给你的好友吧